Patent · US Expired

Use of parvovirus for brain tumor therapy

US7179456B2 · kind B2 · utility

11Cited by

0References

9Claims

0Family size

Assignee

DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS · DE

Inventors

Jean Rommelaere · Heidelberg, DE
Jan Cornelis · Trochtelfingen, DE
Christiane Dinsart · Ladenburg, DE
Jorg Schlehofer · Leimen, DE
Karsten Geletneky · Heidelberg, DE
Marta Herrero Y Calle · Glückstadt, DE

Key dates

Filing date	Apr 30, 2003
Grant date	Feb 20, 2007
Priority date	—
Expiry date	Feb 29, 2024

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2750/14332
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Treatment of brain tumors by a composition including parvovirus, e.g., parvovirus H1, LuIII, Mouse minute virus (MMV), Mouse parvovirus (MPV), Rat minute virus (RMV), Rat parvovirus (RPV), Rat virus (RV), vectors based on the foregoing viral species, and/or cells capable of actively producing the foregoing viral species. Also described is the use of a parvovirus for the preparation of a pharmaceutical composition for the treatment of a brain tumor. Tumors for which the compositions and methods of the invention have particular utility include glioma, medulloblastoma and meningioma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.